Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.

作者: Varki N , Bissonnette M , Wali Rk , Boss Gr , Khare S

DOI:

关键词:

摘要: Azoxymethane (AOM)-induced colonic carcinogenesis involves a number of mutations, including those in the K-ras gene and CTNNB1, that codes for beta-catenin. Prior vitro studies have also demonstrated wild type p21(K-ras) can be activated by epigenetic events. We identified 15 mutations 14 84 AOM-induced tumors three independent methods. By single strand conformational polymorphism, we observed 22 68 exon 3 CTNNB1. A highly sensitive method was then used to measure p21ras activation levels. All assayed possessing had significantly higher levels (8.8 +/- 1.5%; n = 13) compared with control colon (3.7 0.4; 6; P < 0.05) or without such (4.2 0.4%; 70; 0.05). Among wild-type K-ras, there subset (18 70) (8.0 0.9%; 18) colons. In four examined p21ras, increased c-erbB-2 receptor expression decreased Ras-GAP expression. contrast, only one eight ras nonactivated these alterations. Mitogen-activated protein kinase (MAPK) cyclooxygenase-2 (COX-2) were mutated their counterparts. Although beta-catenin did not alter COX-2 MAPK activity, either cyclin D1 but p21-ras, enhanced. Thus, spectrum changes MAPK, COX-2, is distinct among nonmutational p21ras.

参考文章(53)
Jagveer Singh, Nalini Kulkarni, Gary Kelloff, Bandaru S. Reddy, Modulation of azoxymethane-induced mutational activation of ras protooncogenese by chemopreventive agents in colon carcinogenesis Carcinogenesis. ,vol. 15, pp. 1317- 1323 ,(1994) , 10.1093/CARCIN/15.7.1317
W. Schaffner, C. Weissmann, A rapid, sensitive, and specific method for the determination of protein in dilute solution Analytical Biochemistry. ,vol. 56, pp. 502- 514 ,(1973) , 10.1016/0003-2697(73)90217-0
J. S. Scheele, J. M. Rhee, G. R. Boss, Determination of absolute amounts of GDP and GTP bound to Ras in mammalian cells: comparison of parental and Ras-overproducing NIH 3T3 fibroblasts Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 1097- 1100 ,(1995) , 10.1073/PNAS.92.4.1097
Harry M. Lander, David P. Hajjar, Barbara L. Hempstead, Urooj A. Mirza, Brian T. Chait, Sharon Campbell, Lawrence A. Quilliam, A Molecular Redox Switch on p21ras Journal of Biological Chemistry. ,vol. 272, pp. 4323- 4326 ,(1997) , 10.1074/JBC.272.7.4323
Bert Vogelstein, Eric R Fearon, Stanley R Hamilton, Scott E Kern, Ann C Preisinger, Mark Leppert, Yusuke Nakamura, Ray White, Alida MM Smits, Johannes L Bos, Genetic alterations during colorectal-tumor development. The New England Journal of Medicine. ,vol. 319, pp. 525- 532 ,(1988) , 10.1056/NEJM198809013190901
H. Towbin, T. Staehelin, J. Gordon, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 76, pp. 4350- 4354 ,(1979) , 10.1073/PNAS.76.9.4350
K. Otori, K. Sugiyama, S. Fukushima, H. Esumi, Expression of the cyclin D1 gene in rat colorectal aberrant crypt foci and tumors induced by azoxymethane Cancer Letters. ,vol. 140, pp. 99- 104 ,(1999) , 10.1016/S0304-3835(99)00058-0
M. Shtutman, J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, A. Ben-Ze'ev, The Cyclin D1 Gene Is a Target of the beta-catenin/LEF-1 Pathway Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 5522- 5527 ,(1999) , 10.1073/PNAS.96.10.5522
Karen Seibert, Chinthalapally V. Rao, Bandaru S. Reddy, Toshihiko Kawamori, Chemopreventive Activity of Celecoxib, a Specific Cyclooxygenase-2 Inhibitor, against Colon Carcinogenesis Cancer Research. ,vol. 58, pp. 409- 412 ,(1998)
Antony W. Burgess, Hiroshi Maruta, Regulation of the RAS Signalling Network ,(1996)